Reply

Clin Gastroenterol Hepatol. 2019 Jul;17(8):1646-1647. doi: 10.1016/j.cgh.2019.02.003. Epub 2019 Feb 13.

Authors

David Faleck¹, Parambir Dulai², Ryan Ungaro³

Affiliations

¹ Gastroenterology, Hepatology & Nutrition Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
² Division of Gastroenterology, University of California-San Diego, La Jolla, California.
³ Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York.

PMID: 30771499
DOI: 10.1016/j.cgh.2019.02.003

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal, Humanized
Colitis, Ulcerative*
Crohn Disease*
Humans
Time Factors

Substances

Antibodies, Monoclonal, Humanized
vedolizumab